The largest series of abdominal aortic aneurysm with unfavorable neck anatomy

Original title: Outcomes of Endovascular Aneurysm Repair in Patients with Hostile Neck Anatomy Reference: Stather et al. European Journal of Vascular and Endovascular Surgery 44 (2012) 556-561.

Endovascular treatment of abdominal aortic aneurysms (EVAR) has already shown benefits in terms of mortality compared with conventional surgery. 

The disadvantages of EVAR are reinterventions for endoleaks, migration or device failure and these could be related to an unfavorable anatomy. 

The objective of this study was to compare the results in EVAR patients with a favorable neck versus an unfavorable neck, which is defined as one with at least one of the following characteristics: diameter greater than 28 mm, angle> 60 ° , length

The study included 552 consecutive patients receiving EVAR between January 1999 and July 2010 at one hospital with an average follow-up of 4.1 years. Of the total number of patients, 199 (36.1%) had an unfavorable neck. There were no differences in baseline characteristics between the groups. The devices used were: Cook Zenith, Medtronic Talent/Endurant and Gore Excluder. At follow-up after 30 days there was no difference between groups in procedural failure (CF 0,6% vs. CD 2%; p=0,12), mortality (CF 1,1% vs. CD 0,5%; p=0,45), endoleak type 1 (CF 0,8% vs. CD 2,5%; p=0,12) or reoperation (CF 2,8% vs. CD 5%; p=0,12).

In longer term follow-up, (average 4 years), we observed a higher incidence of endoleak type I in unfavorable neck (4.5% vs. 9.5%, P = 0.02) but, conversely, increased incidence of endoleak in favorable necks (16.7% vs. 10.6%, p <0.05). There were no group differences in device migration (2.5% versus CF. CD 3%, P = 0.75), expansion of the bag (CF 13% vs. CD 9.5%; p=0.22), aneurysm rupture (CF 1,1% vs. CD 3.5%; p=0,05) or mortality (CF 15.1% vs. CD 14.6%; p=0,86). The difference was significant in the number of reoperations for patients with an unfavorable neck (CF 11% vs. CD 22.8%; p<0.01).

Conclusion 

Patients with abdominal aortic aneurysm and an unfavorable neck can be treated as endovascular with equally long-term mortality as favorable neck patients but with a higher incidence of endoleak type I and reintervention.

Editorial Comment:

The larger serial with longer follow up published by EVAR with an unfavorable neck shows the feasibility and safety of the procedure but also the need for careful monitoring in the long term. While unfavorable necks had a higher incidence of reoperations, these were mostly to treat leaks type I B and type II, which hardly relate to the anatomy of the neck. One limitation of the study is that it was conducted in a single center which takes away external validity and this is no minor fact when facing a challenging anatomy where experience must play a fundamental role.

SOLACI.ORG

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...